Company Summary - International Biotechnology Trust PLC (LSE:IBT)
Equity Investment InstrumentsMarket cap: £77.008m
Review a company's summary page in more detail and see the key fundamentals at a glance. Sign-up to Premium now to make your investment decisions.
Sign-up to Premium's Free 7 Day trial See an improved company summary
Summary
To achieve long term capital growth by investing in high growth, development stage biotechnology companies that are either quoted or unquoted
| Financials - Annual Report (31/08/2009) | ||
|---|---|---|
| EPS | p | -1.8 |
| DPS | p | - |
| Dividend Yield | % | |
| Director | Board Role |
|---|---|
| Andrew Barker | Chairman |
Products Brands & Subsidiaries
Products & Brands
There are no products for this company.
Subsidiaries
IBT (2004) Ltd
| Heading | Date |
|---|---|
| Annual Information Update | 20/11/2009 |
| Net Asset Value(s) | 20/11/2009 |
| Transaction in Own Shares | 19/11/2009 |
